Abstract
Apoptosis, or programmed cell death, is a physiological mechanism by which the cell fragments its DNA and “commits suicide” in a controlled way (Coultas and Strasser 2000). The mechanisms of apoptosis are natural and even protect against uncontrolled cellular growth as well as playing a very important role in all development systems: embryogenesis, hematopoietic differentiation and proliferation, control of tumor proliferation, and regulation of immune activation (Holtzman et al. 2000). In the particular context of the immune system, apoptosis is a highly regulated form of cell death that is essential for maintaining a constant lymphocyte population size in the face of the continuous influx of new lymphocytes and homeostatic proliferation of existing cells (Khaled and Durum 2002). In addition, it is required during an immune response to foreign antigens in order to eliminate most activated antigen-specific T-cells and thereby prevent autoimmunity (Hilderman et al. 2002). Cell death occurs through two main pathways: activation-induced cell death, which is initiated by the binding of tumour-necrosis factor family death-receptor ligands to their cognate death receptors (the extrinsic pathway), and activated T-cell autonomous death, which is mediated by Bc12-related proteins (the intrinsic pathway) and is initiated by internal sensors that transmit signals to the mitochondria (Kramer 2000; Martinou and Green 2001).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aceituno E, Castanon S, Jimenez C, Subira D, De Gorgolas M, Fernandez-Guerrero M, Ortiz F, Garcia R (1997) Circulating immune complexes from HIV-1+ patients induces apoptosis on normal lymphocytes. Immunology 92: 317–320
Akari H, Bour S, Kao S, Adachi A, Strebel K (2001) The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors J Exp Med 194: 1299–1311
Alcami J, Lain de Lera T, Folgueira L, Pedraza MA, Jacque JM, Bachelerie F, Noriega AR, Hay RT, Harrich D, Gaynor RB, Virelizier JL, Arenzana F (1995) Absolute dependence on kB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J 14: 1552–1560
Ameisen JC (2001) Apoptosis subversion: HIV-Nef provides both armor and sword. Nat Med 7: 1181–1182
Ameisen JC, Capron A (1991) Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today 12: 102–105
Arenzana-Seisdedos F, Turpin P, Rodriguez M, Thomas D, Hay RT, Virelizier JL, Dargemont C (1997) Nuclear localization of IkBa promotes active transport of NFKB from the nucleus to the cytoplasm. J Cell Sci 110: 369–378
Ashkenazi A (2002) Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2: 420–430
Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281:1305–1308 Ashkenazi A, Dixit VM (1999) Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11: 255–260
Ayavoo V, Mahboubi A, Mahalingam S, Ramalingam R, Kudchodkar S, Williams WV, Green DR, Weiner DB (1997) HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat Med 3: 1117–1123
Badley AD, Pilon AA, Landay A, Lynch DH (2000) Mechanisms of HIV associated lymphocyte apoptosis. Blood 96: 2951–2964
Bachelerie F, Alcami J, Arenzana F, Virelizier JL (1991). HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes. Nature 350 709–712
Baeuerle PA, Baltimore D (1988) Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell 53: 211–217
Balachandran S, Kim CN, Yeh WC, Mak TW, Bhalla K, Barber GN (1998) Activation of the dsRNAdependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J 17: 6888–6902
Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly RP, Finkel TH (1992) Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 176: 1099–1106
Barkett M, Gilmore TD (1999) Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 18: 6910–6924
Bartz SR, Emerman M (1999) Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8. J Virol 73: 1956–1963
Basanez G, Zimmerberg J (2001) HIV and apoptosis death and the mitochondrion. J Exp Med 193: 509–519
Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D (1995) Embryonic lethality and liver degeneration in mice lacking the Re1A component of NF-kappa B. Nature 376: 167–170
Behrmann I, Walczak H, Krammer PH (1994) Structure of the human APO-1 gene. Eur J Immunol 24: 3057–3062
Ben Neriah Y (2002) Regulatory functions of ubiquitination in the immune system. Nat Immunol 3: 20–26
Benedict CA, Norris PS, Ware CF (2002) To kill or be killed: viral evasion of apoptosis. Nat Immunol 3: 1013–1018
Berger EA, Murphy PM, Farber JM (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17: 657–700
Bermejo M, Martin-Serrano J, Oberlin E, Pedraza MA, Serrano A, Santiago B, Caruz A, Loetscher P, Baggiolini M, Arenzana-Seisdedos F, Alcami J (1998) Activation of blood T lymphocytes down-regulates CXCR4 expression and interferes with propagation of X4 HIV strains. Eur J Immunol 28: 3192–3204
Blanco J, Barretina J, Henson G, Bridger G, De Clercq E, Clotet B, Este JA (2000) The CXCR4 antagonist AMD3100 efficiently inhibits cell-surface-expressed human immunodeficiency virus type 1 envelope-induced apoptosis. Antimicrob Agents Chemother 44: 51–56
Blanco J, Barretina J, Ferri KF, Jacotot E, Gutierrez A, Armand-Ugon M, Cabrera C, Kroemer G, Clotet B, Este JA (2003) Cell-surface-expressed HIV-1 envelope induces the death of CD4 T cells during gp41-mediated hemifucion-like events. Virology 305: 318–329
Blackson JN, Persaud D, Siliciano RF (2002) The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med 53: 557–593
Boise LH, Thompson CB (1996) Hierarchical control of lymphocyte survival. Science 274:67–68 Brenner C, Kroemer G (2003) The mitochondriotoxic domain of Vpr determines HIV-1 virulence. J Clin Invest 111: 1455–1457
Brodie SJ, Lewinsohn DA, Patterson BK, Jiyamapa D, Krieger J, Corey L, Greenberg PD, Riddell SR (1999) In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat Med 5: 34–41
Casano FJ, Rolando AM, Mudgett, JS, Molineaux SM (1994) The structure and complete nucleotide sequence of the murine gene encoding interleukin-1 beta converting enzyme ( ICE ). Genomics 20: 474–481
Casella CR, Rapaport EL, Finkel TH (1999) Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing J Virol 73: 92–100
Castedo M, Roumier T, Blanco J, Ferri KF, Barretina J, Tintignac LA, Andreau K, Perfettini JL, Amendola A, Nardacci R, Leduc P, Ingber DE, Druillennec S, Roques B, Leibovitch SA, VilellaBach M, Chen J, Este JA, Modjtahedi N, Piacentini M, Kroemer G (2002) Sequential involvement of Cdkl, mTOR and p53 in apoptosis induced by the HIV-1 envelope. EMBO J 21: 4070–4080
Chen D, Wang M, Zhou S, Zhou Q (2002) HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bd-2 relative Bim. EMBO J 21: 6801–6810
Chen G, Goeddel DV (2002) TNF-R1 signaling: a beautiful pathway. Science 296:1634–1635 Chinnaiyan AM, O’Rourke K, Tewari M, Dixit VM (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505–512
Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, Lloyd AL, Nowak MA, Fauci AS (1997) Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 94: 13193–13197
Chu WM, Ostertag D, Li ZW, Chang L, ChenY, Hu Y, Williams B, Perrault J, Karin M (1999) JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity 11: 721–731
Cicala C, Arthos J, Rubbert A, Selig S, Wildt K, Cohen OJ, Fauci AS (2000) HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells. Proc Natl Acad Sci USA 97: 1178–1183
Clemens MJ, Elia A (1997) The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res 17: 503–524
Cloyd MW, Chen JJ, Adeqboyega P, Wang L (2001) How does HIV cause depletion of CD4 lymphocytes? A mechanism involving virus signaling through its cellular receptors. Curr Mol Med 1: 545–550
Connolly JL, Rodgers SE, Clarke P, Ballard DW, Kerr LD, Tyler KL, Dermody TS (2000) Reovirusinduced apoptosis requires activation of transcription factor NF-kappaB. J Virol 74: 2981–2989
Coultas L, Strasser A (2000) The molecular control of DNA damage-induced cell death. Apoptosis 5: 491–507
Cuddihy AR, Li S, Tam NW, Wong AH, Taya Y, Abraham N, Bell JC, Koromilas AE (1999a) Doublestranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. Mol Cell Biol 19: 2475–2484
Cuddihy AR, Wong AH, Tam NW, Li S, Koromilas AE (1999b) The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene 18: 2690–2702
Cullen BR (1993) Does HIV-1 Tat induce a change in viral initiation rights? Cell 73:417–420 Delhase M, Hayakawa M, Chen Y, Karin M (1999) Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284: 309–313
DeLuca C, Kwon H, Lin R, Wainberg M, Hiscott J (1999) NF-kappaB activation and HIV-1 induced apoptosis. Cytokine Growth Factor Rev 10: 235–253
DeLuca C, Roulston A, Koromilas A, Wainberg MA, Hiscott J (1996) Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradation. J Virol 70: 51835193
De Martino GN, Slaughter CA (1999) The proteasome, a novel protease regulated by multiple mechanisms. J Biol Chem 274: 22123–22126
Der SD, Yang YL, Weissmann C, Williams BR (1997) A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc Natl Acad Sci USA 94: 3279–3283
DiDonato J, Mercurio F, Rosette C, Wu LJ, Suyang H, Ghosh S, Karin M (1996) Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol 16: 1295–1304
Doi TS, Marino MW, Takahashi T, Yoshida T, Sakakura T, Old LJ, Obata Y (1999) Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci USA 96: 2994–2999
Dumont A, Hehner SP, Hofmann TG, Ueffing M, Droge W, Schmitz ML (1999) Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. Oncogene 18: 747–757
Emerman M, Malim MH (1998) HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science 280: 1880–1884
Estaquier J, Lelievre JD, Petit F, Brunner T, Moutouh-De Parseval L, Richman DD, Ameisen JC, Corbeil J (2002) Effects of antiretroviral drugs on human immunodeficiency virus type 1-induced CD4(+) T-cell death. J Virol 76: 5966–5973
Fackler OT, Baur AS (2002) Live and let die: Nef functions beyond HIV replication Immunity 16: 493–497
Ferri KF, Jacotot E, Blanco J, Este JA, Kroemer G (2000) Mitochondrial control of cell death induced by HIV-1-encoded proteins. Ann NY Acad Sci 926: 149–164
Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, Kupfer A (1995) Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med 1: 129–134
Foo SY, Nolan GP (1999) NF-kappaB to the rescue: RELs, apoptosis and cellular transformation. Trends Genet 15: 229–235
Geiss GK, Bumgarner RE, An MC, Agy MB, van ‘t Wout AB, Hammersmark E, Carter VS, Upchurch D, Mullins JI, Katze MG (2000) Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. Virology 266: 8–16
Geleziunas R, Xu W, Takeda K, Ichijo H, Greene WC (2001) HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 410: 834–838
Ghosh S, May MJ, Kopp EB (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225–260
Gibellini D, Re MC, Ponti C, Maldini C, Celeghini C, Cappellini A, La Placa M, Zauli G (2001) HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNFrelated apoptosis-inducing ligand. Cell Immunol 207: 89–99
Gil J, Alcamí J, Esteban M (1999) Induction of apoptosis by double-stranded RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB. Mol Cell Biol 19: 4653–4663
Gil J, Alcamí J, Esteban M (2000) Activation of NF-kappaB by the dsRNA-dependent protein kinase, PKR involves the IkappaB kinase complex. Oncogene 19: 1369–1378
Gil J, Esteban M (2000a) FADD-mediated activation of caspase 8 by a mechanism independent of Fas and TNFR is involved in PKR-induced apoptosis. Oncogene 19: 3665–3674
Gil J, Esteban M (2000b) Role of the protein kinase PKR in apoptosis induction. Apoptosis 5: 107–114
Gil J, Ruilas J, García M, Alcamí J, Esteban M (2001) The catalytic activity of the dsRNA-dependent protein kinase, PKR, is required for NF-kB activation. Oncogene 20: 385–394
Gil J, Garcia M, Esteban M (2002) Caspase 9 activation by the dsRNA-dependent protein kinase, PKR: molecular mechanism and relevance, FEBS Lett 529: 249–255
Glushakova S, Grivel JC, Fitzgerald W, Sylwester A, Zimmerberg J, Margolis LB (1998) Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency. Nat Med 4: 346–349
Glushakova S, Yi Y, Grivel JC, Singh A, Schols D, De Clercq E, Collman RG, Margolis L (1999) Preferential coreceptor utilization and cytopathicity by dual-tropic HIV- 1 in human lymphoid tissue ex vivo. J Clin Invest 104: R7 - R11
Gougeon ML (2003) Apoptosis as an HIV strategy to escape immune attack. Nat Rev Immunol 3: 392–404
Gougeon ML, Montagnier L (2000) Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy. Ann NY Acad Sci 887: 199–212
Greene WC, Peterlin BM (2002). Charting HIV’s remarkable voyage through the cell: basic science as a passport to future therapy. Nat Med 8 673–680
Greenway AL, McPhee DA, Allen K, Johnstone R, Holloway G, Mills J, Azad A, Sankovich S, Lambert P (2002) Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis. J Virol 76: 2692–2702
Grivel JC, Margolis LB (1999) CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Nat Med 5: 344–346
Groux H, Torpier G, Monte D, Mouton Y, Capron A, Ameisen JC (1992) Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 175: 331–340
Guillerm C, Coudronniere N, Robert-Hebmann V, Devaux C (1998) Delayed human immunodeficiency virus type 1-induced apoptosis in cells expressing truncated forms of CD4. Virology 72: 1754–1761
Haase AT, Henry K, Zupancic M, Sedgewick G, Faust RA, Melroe H, Cavert W, Gebhard K, Staskus K, Zhang ZQ, Dailey PJ, Balfour HH Jr, Erice A, Perelson AS (1996) Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274: 985–989
Hashimoto F, Oyaizu N, Kalyanaraman VS, Pahwa S (1997) Modulation of Bd-2 protein by CD4 cross-linking: a possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2. Blood 90: 745–753
Haughey NJ, Mattson MP (2002) Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. J Acquir Immune Defic Syndr 31 (Suppl 2): S55–61
Hay S, Kannourakis G (2002) A time to kill: viral manipulation of the cell death program. J Gen Virol 83: 1547–1564
Hazenberg MD, Otto SA, Cohen Stuart JW, Verschuren MC, Borleffs JC, Boucher CA, Coutinho RA, Lange JM, Rinke de Wit TF, Tsegaye A, van Dongen JJ, Hamann D, de Boer RJ, Miedema F (2000a) Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med 6: 10361042
Hazenberg MD, Hamann D, Schuitemaker H, Miedema F (2000b) T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol 1: 285–289
Hazenberg MD, Borghans JA, de Boer RJ, Miedema F (2003) Thymic output: a bad TREC record. Nat Immunol 4: 97–99
Hettmann T, DiDonato J, Karin M, Leiden JM (1999) An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis. J Exp Med 189: 145–158
Hilderman DA, Zhu Y, Mitchell TC, Kappler J, Marrack P (2002) Molecular mechanisms of activated T cell death in vivo. Curr Opin Immunol 14: 354–359
Holtzman MJ, Green JM, Jayaraman S, Arch RH (2000) Regulation of T cell apoptosis. Apoptosis 5: 459–471
Hsu H, Xiong J, Goeddel DV (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81: 495–504
Hsu H, Shu HB, Pan MG, Goeddel DV (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.Cell 84: 299–308
Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388: 190–195
Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HL, Zamzami N, Costantini P, Druillennec S, Hoebeke J, Briand JP, Irinopoulou T, Daugas E, Susin SA, Cointe D, Xie ZH, Reed JC, Roques BP, Kroemer G (2000) The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med 191: 33–46
Jaworowski A, Crowe SM (1999) Does HIV cause depletion of CD4+ T cells in vivo by the induction of apoptosis? Immunol Cell Biol 77: 90–98
Jekle A, Keppler OT, De Cleck E, Weinstein M, Goldsmith MA (2003) In vivo evolution of human immunodeficiencecy virus type I toward increased pathogenicity through CXR4-mediated killing of uninfected CD4 T cells. J Virol 77: 5846–5854
Jimenez A, Molero L, Jimenez A, Castanon S, Subira D, De Gorgolas M, Fedz-Guerrero M, Garcia R (2002) Role of antiretroviral regimes in HIV-1 patients in reducing immune activation. Immunology 106: 80–86
Kameoka M, Kimura T, Zheng YH, Suzuki S, Fujinaga K, Luftig RB, Ikuta K (1997) Protease-defective, gp120-containing human immunodeficiency virus type 1 particles induce apoptosis more efficiently than does wild-type virus or recombinant gp120 protein in healthy donor-derived peripheral blood T cells. J Clin Microbiol 35: 41–47
Karin M (1999) The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem 274: 27339–27342
Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3:221–227 Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, Green DR (1998) DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol Cell 1: 543–551
Khaled AR, Durum SK (2002) Lymphocide: cytokines and the control of lymphoid homeostasis. Nat Rev Immunol 2: 817–830
Kim TA, Avraham HK, Koh YH, Jiang S, Park IW, Avraham S (2003) HIV-1 Tat-mediated apoptosis in human brain microvascular endothelial cells J Immunol 170: 2629–37
Kinter A,Arthos J, Cicala C, Fauci AS (2000) Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis Immunol Rev 177: 88–98
Krammer PH (2000) CD95’s deadly mission in the immune system. Nature 407: 789–795
Kumar A, Yang YL, Flati V, Der S, Kadereit S, Deb A, Hague J, Reis L, Weissmann C, Williams BR (1997) Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J 16: 406–416
Kwon H, Pelletier N, DeLuca C, Genin P, Cisternas S, Lin R, Wainberg MA, Hiscott J (1998) Inducible expression of IkappaBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells. J Biol Chem 2 73: 7431–7440
LaBonte JA, Madani N, Sodroski J (2003) Cytolysis by CCR5 using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression J Virol 77: 6645–6659
Laurent-Crawford AG, Krust B, Riviere Y, Desgranges C, Muller S, Kieny MP, Dauguet C, Hovanessian AG (1993) Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res Hum Retroviruses 9: 761–773
Lee SB, Esteban M (1994) The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 199: 491–496
Leo E, Deveraux QL, Buchholtz C, Welsh K, Matsuzawa S, Stennicke HR, Salvesen GS, Reed JC (2001) TRAF1 is a substrate of caspases activated during tumor necrosis factor receptoralpha-induced apoptosis. J Biol Chem 276: 8087–8093
Levkau B, Scatena M, Giachelli CM, Ross R, Raines EW (1999) Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop. Nat Cell Biol 1999 1: 227–233
Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB (1995) Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268: 429–431
Li Q, Verma I (2002) NF-kB regulation in the immune system. Nat Rev Immunol 2: 725–734
Lin Y, Devin A, Rodriguez Y, Liu ZG (1999) Cleavage of the death domain kinase RIP by caspase8 prompts TNF-induced apoptosis. Genes Dev 13: 2514–2526
Liu ZG, Hsu H, Goeddel DV, Karin M (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87: 565–576
Lum JJ, Cohen OJ, Nie Z, Weaver JG, Gomez TS, Yao XJ, Lynch D, Pilon AA, Hawley N, Kim JE, Chen Z, Montpetit M, Sanchez-Dardon J, Cohen EA, Badley AD (2003) Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis J Clin Invest 111: 1547–1554
Martinou JC, Green DR (2001) Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2:63–67 May MJ, Ghosh S (1997) Rel/NF-kappa B and I kappa B proteins: an overview. Semin Cancer Biol 8: 63–73
Matarrese P, Gambardella L, Cassone A, Vella S, Cauda R, Malorni W (2003) Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitors. J Immunol 170: 6006–6015
McCloskey TW, Ott M, Tribble E, Khan SA, Teichberg S, Paul MO, Pahwa S, Verdin E, Chirmule N (1997) Dual role of HIV Tat in regulation of apoptosis in T cells. J Immunol 158: 1014–1019
McCune JM (2001) The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410: 974–979
Meurs E, Chong K, Galabru J, Thomas NS, Kerr IM, Williams BR, Hovanessian AG (1990) Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62: 379–390
Moutouh L, Estaquier J, Richman DD, Corbeil J (1998) Molecular and cellular analysis of human immunodeficiency virus-induced apoptosis in lymphoblastoid T-cell-line-expressing wild-type and mutated CD4 receptors. J Virol 72: 8061–8072
Muthumani K, Hwang DS, Desai BM, Zhang D, Dayes N, Green DR, Weiner DB (2002) HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells J Biol Chem 277: 37820–37831
Muthumani K, Choo AY, Hwang DS, Chattergoon MA, Dayes NN, Zhang D, Lee MD, Duvvuri U, Weiner DB (2003) Mechanism of HIV-1 viral protein R-induced apoptosis Biochem Biophys Res Commun 304: 583–592
Muzio M, Chinnaiyan AM, Kischkel FC, O’Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM (1996) FLICE, a novel FADDhomologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817–827
Nagata S (1997)Apoptosis by death factor. Cell 86:355–365
Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V, Hurley A, Markowitz M, Ho DD, Nixon DF, McMichael AJ (1998) Quantitation of HIV-1 specific cytotoxic T-lymphocytes and plasma load of viral RNA. Science 279: 2103–2106
Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS, Pahwa S (1993) Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82: 3392–3400
Oyaizu N, McCloskey TW, Than S, Hu R, Kalyanaraman VS, Pahwa S (1994) Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion. Blood 84: 2622–2631
Pahl HL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853–6866
Parker NG, Notermans DW, de Boer RJ, Roos MT, de Wolf F, Hill A, Leonard JM, Danner SA, Miedema F, Schellekens PT (1998) Biphasic kinetics of peripheral blood T cells after tripe combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 4: 208–214
Penn ML, Grivel JC, Schramm B, Goldsmith MA, Margolis L (1999) CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue Proc Natl Acad Sci USA 96: 663–668
Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD (1996) HIV1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582–1586
Perkins ND, Schmid RM, Ducket CS, Leung K, Rice NR, Nabel GJ (1992) Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation. Proc Natl Acad Sci USA 89: 1529–1533
Persaud D, Zhou Y, Siliciano JM, Siliciano RF (2003) Latency in human immunodeficiency virus type 1 infection: no easy answers J Virol 77: 1659–65
Peterlin BM and Trono D (2003). Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat Rev Immunol 3 97–107
Phenix BN, Cooper C, Owen C, Badley AD (2002) Modulation of apoptosis by HIV protease inhibitors. Apoptosis 7: 295–312
Reuther JY, Baldwin AS Jr (1999) Apoptosis promotes a caspase-induced amino-terminal truncation of IkappaBalpha that functions as a stable inhibitor of NF-kappaB. J Biol Chem 274: 20664–20670
Rothe M, Sarma V, Dixit VM, Goeddel DV (1995) TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269: 1424–1427
Rothwarf DM, Zandi E, Natoli G, Karin M (1998) IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 395: 297–300
Roulston A, Marcellus RC, Branton PE (1999) Viruses and apoptosis. Annu Rev Microbiol 53 577–628
Sen R, Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705–716
Shostak LD, Ludlow J, Fisk J, Pursell S, Rimel BJ, Nguyen D, Rosenblatt JD, Planelles V (1999) Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr. Exp Cell Res 251: 156–165
Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA (1986) Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 322: 470–474
Somasundaran M, Sharkey M, Brichacek B, Luzuriaga K, Emerman M, Sullivan JL, Stevenson M (2002) Evidence for a cytopathogenicity determinant in HIV-1 Vpr. Proc Natl Acad Sci USA 99: 9503–9508
Speth C, Dierich MP (1999) Modulation of cell surface protein expression by infection with HIV-1. Leukemia 13 (Suppl 1): S99–105
Srivastava SP, Kumar KU, Kaufman RJ (1998) Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. J Biol Chem 273: 2416–2423
Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67: 227–264
Stewart SA, Poon B, Song JY, Chen IS (2000) Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation. J Virol 74: 3105–3111
Sylwester AW, Grivel JC, Fitzgerald W, Rossio JL, Lifson JD, Margolis LB (1998) D4(+) T-lymphocyte depletion in human lymphoid tissue ex vivo is not induced by noninfectious human immunodeficiency virus type 1 virions. J Virol 72: 9345–9347
Takahashi M, Osono E, Nakagawa Y, Wang J, Berzofsky JA, Margulies DH (2002) Rapid induction of apoptosis in CD8+ HIV-1 envelope-specific murine CTLs by short exposure to antigenic peptide. J Immunol 169: 6588–6593
Takizawa T, Ohashi K, Nakanishi Y (1996) Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J Virol 70: 8128–8132
Tang G, Yang J, Minemoto Y, Lin A (2001) Blocking caspase-3-mediated proteolysis of IKKbeta suppresses TNF-alpha-induced apoptosis. Mol Cell 8: 1005–1016
Van Antwerp D, Martin SJ, Kafri T, Green DR, Verma IM (1996) Suppression of TNF-alphainduced apoptosis by NF-kappaB. Science 274: 787–789
van ‘t Wout AB, Lehrman GK, Mikheeva SA, O’Keeffe GC, Katze MG, Bumgarner RE, Geiss GK, Mullins JI (2003) Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines. J Virol 77: 1392–1402
Wang CY, Mayo MW, Baldwin A] (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274: 784–787
Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin, A] (1998) NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c- IAP2 to suppress caspase-8 activation. Science 281: 1680–1683
Weiss RA (1996) HIV receptors and the pathogenesis of AIDS. Science 272:1885–1886 Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375: 497–500
Wolf D, Witte V, Laffert B, Blume K, Stromer E, Trapp S, d’Aloja P, Schurmann A, Baur AS (2001) HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals Nat Med 7: 1217–1224
Wolf T, Findhammer S, Nolte B, Helm EB, Brodt HR (2003) Inhibition of TNF-alpha mediated cell death by HIV-1 specific protease inhibitors. Eur J Med Res 28: 17–24
Wu H, Lozano G (1994) NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem 269: 20067–20074
Wyatt R, Sodroski J (1998) The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280: 1949–1953
Xu XN, Screaton G (2001) HIV-1 Nef: negative effector of Fas? Nat Immunol 2: 384–385
Xu XN, Screaton GR, Gotch FM, Dong T, Tan R, Almond N, Walker B, Stebbings R, Kent K, Nagata S, Stott JE, McMichael AJ (1997) Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells J Exp Med 186: 7–16
Yang Y, Dong B, Mittelstadt PR, Xiao H, Ashwell JD (2002) HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter. J Biol Chem 277: 19482–19487
Yang Y, Tikhonov I, Ruckwardt TJ, Djavani M, Zapata JC, Pauza CD, Salvato MS (2003) Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism. J Virol 77: 6700–6708
Yeh WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El DW, Lowe SW, Goeddel DV, Mak TW (1998) FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279: 1954–1958
Yeh WC, Hakem R, Woo M, Mak TW (1999) Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling. Immunol Rev 169: 283–302
Yeung MC, Chang DL, Camantigue RE, Lau AS (1999) Inhibitory role of the host apoptogenic gene PKR in the establishment of persistent infection by encephalomyocarditis virus in U937 cells. Proc Natl Acad Sci USA 96: 11860–11865
Yuan H, Xie YM, Chen IS (2003) Depletion of Wee-1 kinase is necessary for both human immunodeficiency virus type 1 Vpr-and gamma irradiation-induced apoptosis. J Virol 77: 2063–2070
Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61: 213–222
Zauli G, Gibellini D, Secchiero P, Dutartre H, Olive D, Capitani S, Collette Y (1999) Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway. Blood 93: 1000–1010
Zhang M, Li X, Pang X, Ding L, Wood O, Clouse KA, Hewlett I, Dayton AI (2002) Bd-2 upregulation by HIV-1 Tat during infection of primary human macrophages in culture. J Biomed Sci 9: 133–139
Zhu Y, Roshal M, Li F, Blackett J, Planelles V (2003) Upregulation of survivin by HIV-1 Vpr. Apoptosis 8: 71–79
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bermejo, M., Alcamí, J., Gil, J. (2004). HIV and Apoptosis: a Complex Interaction Between Cell Death and Virus Survival. In: Alonso, C. (eds) Viruses and Apoptosis. Progress in Molecular and Subcellular Biology, vol 36. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-74264-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-540-74264-7_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-74263-0
Online ISBN: 978-3-540-74264-7
eBook Packages: Springer Book Archive